Weight-loss tablets love GLP-1s are easy to aquire on-line, elevating overdose and issues of security

Within 24 hours of injecting the first dose of a weight loss medication she obtained following a visit with a telehealth doctor, Karleigh McClain change into admitted to the successfully being heart, she said.

The 31-year-ragged compliance advisor from Hendersonville, Tennessee, said she couldn’t stay vomiting.

“Sunday morning, it all hits,” McClain recalled, as she described what came about that weekend in January. “I will’t have anything down.”

McClain said she understanding the dosage the telehealth company had prescribed gave the influence too high. She tried to contact her doctor, however when she didn’t salvage a straight away response, she said she called the corporate and a “care personnel” representative confirmed the directions — which said to inject 2.21 milligrams of the semaglutide medication as soon as a week — had been factual.

It turned out, nonetheless, that change into practically 9 cases the amount sufferers are on the total told to rob for his or her first dose.

On the arena of a month after she change into identified with an overdose, McClain said she change into “smooth dealing with the residual aspect effects,” including an elevated heart price and vision issues she felt had been tied to the medication.

Most sufferers who appreciate taken a GLP-1 obtained their prescription through a first-rate care doctor or a specialist, KFF polling files exhibits. But as the uptake of telehealth has grown substantially since the launch of the Covid pandemic, McClain is one of hundreds and hundreds of Individuals who appreciate archaic on-line companies to meet a diversity of their scientific needs.

A variety of the companies appreciate started offering GLP-1 medications for weight loss as set up a query to for these tablets has exploded. But definite medication errors tied to GLP-1s appreciate exploded too, per a KFF Effectively being Recordsdata review of Meals and Drug Administration files, and physicians and telemedicine researchers anguish that adversarial experiences tied to telehealth companies are becoming extra total.

Deplorable outcomes aren’t distinctive to telehealth suppliers or to the compounded weight loss tablets many of them provide. Truly, product liability complaints alleging patient accidents were filed overwhelmingly in opposition to pharmaceutical giants Eli Lilly and Novo Nordisk, which get title-imprint weight loss tablets, court docket files exhibits. The drugmakers appreciate defended their products.

On the other hand, some critics are also eager that getting a weight loss prescription on-line is mostly necessary more straightforward than getting one through an in-particular person appointment. No longer splendid ruin many telehealth companies write rapidly prescriptions for GLP-1s, however they frequently sell the medications, too, allowing sufferers to bypass in-particular person pharmacy visits. This one-stay shopping isn’t essentially a factual thing, per critics who vow some telehealth suppliers are writing prescriptions for those who must no longer be taking GLP-1s and then offering exiguous or no practice-up care.

“It affords a unlit peek to telemedicine,” said Elizabeth Krupinski, an experimental psychologist at Emory University who has performed learn on the effectiveness of telehealth.

Telemedicine stands to support “so many folks,” Krupinski said, in particular when the skills is built-in inside an even bigger healthcare system. That formulation, sufferers appreciate the good thing about the convenience of telehealth whereas affirming a reference to their in-particular person suppliers.

But some telehealth companies are marketing GLP-1s as an easy technique to shed weight — generally with the assist of paid celeb endorsements — with out emphasizing the importance of healthy eating and exercise, she said.

They’ll also fair be following the letter of the law, Krupinski said. But writing prescriptions whereas skimping on care “is no longer in the Hippocratic oath.”

A ‘splendid storm’

Beginning around 2020, many states loosened restrictions on telehealth, which allowed on-line companies to proliferate. This helped accommodate sufferers who can also no longer, or chose no longer to, be viewed in particular person at the peak of Covid transmission.

Expanded telehealth salvage entry to change into also supposed to diminish boundaries in rural communities, besides mitigate doctor and nurse shortages. In many locations, telehealth doctors and nurses are legally allowed to handle sufferers across vow traces. But the formulation telemedicine is practiced varies extensively, and vow regulations largely dictate suggestions that telehealth suppliers must practice.

Some companies, equivalent to Mochi Effectively being, require sufferers to meet nearly about with a supplier, equivalent to a doctor, nurse practitioner, or doctor assistant, sooner than they’re going to salvage a GLP-1 prescription.

But others, including Ro, generally require nothing extra of sufferers than an “asynchronous” evaluation, which does no longer encompass a stay conversation with a healthcare supplier. For the interval of such a evaluation, prospects are on the total requested to hang out an consumption get and answer a scientific history questionnaire sooner than they’re evaluated for a prescription. Ro requires a conversation in steady time when required by vow law, or when requested by a patient or clinician, said Nicholas Samonas, a spokesperson for the corporate.

Some health workers are eager that digital care can also fair be insufficient for prescribing weight loss tablets.

Patients with a history of pancreatitis, as an instance, must be counseled about capability issues, scientific stories mark. The identical goes for oldsters with a condition called gastroparesis, which affects abdomen nerves and muscles, and americans liable to medullary thyroid cancer.

Some sufferers can also fair even appreciate the good thing about blood work or muscular tissues screening sooner than starting up a GLP-1.

But no longer all telehealth companies are adequately evaluating sufferers sooner than writing prescriptions, said Marc-Andre Cornier, an endocrinologist at the Clinical University of South Carolina and the prompt past president of The Obesity Society.

By formulation of parsing the factual from the abominable, “whose job is it to police that?” he requested. The scenario, he said, is there aren’t criteria written by a authorities agency or a scientific society to search out out which suppliers are treating sufferers accurately and which aren’t.

While the first GLP-1 change into authorized by the FDA extra than twenty years ago, to handle Kind 2 diabetes, the usage of these tablets took off in 2021 when Novo Nordisk obtained approval for a semaglutide drug to handle obesity, with the imprint title Wegovy. In a 2025 KFF poll, practically 1 in 5 adults said that they had taken a GLP-1.

In a latest paper in The Contemporary England Journal of Treatment, doctor Amanda Banks eminent that the proportion of GLP-1 prescriptions written for those who had been no longer diabetic, chubby, or overweight elevated from 4.5% in 2018 to 17% in 2023.

Within the paper, Banks called it “troubling” how easy it is to carry out a prescription for weight loss tablets and skittish they’ll also exacerbate novel eating disorders or cause new cases, including of anorexia.

Cornier, who has obtained compensation from Novo Nordisk for serving as a expert, echoed about a of Banks’ issues. “It’s no longer correct filling out a get on-line and then having some random healthcare supplier signal off on it,” he said. “There are issues with a majority of these on-line programs that there’s no longer a correct evaluation, there’s no longer a baseline, and there’s no longer correct supervision.”

The American Telemedicine Affiliation, which advocates for the expansion of “digitally enabled care,” has no longer addressed how telehealth suppliers prescribe GLP-1s, spokesperson Gina Cella said.

“Here’s a exiguous bit out of our scope,” Cella said, when requested if the affiliation had addressed the topic of telehealth suppliers and GLP-1 prescriptions.

The dearth of clarity makes picking an organization doubtlessly complicated for sufferers, and the scientific occupation is partly responsible, said Jamy Ard, an obesity doctor and researcher at Wake Forest University College of Treatment in Winston-Salem, North Carolina.

Doctors appreciate historically performed a abominable job counseling sufferers about weight loss, and a couple of folks aren’t cosy talking to their major care doctor about it, Ard said. Patients judge, “Why would I will my doctor and appreciate them vow, ‘Eat much less and transfer extra,’ after I appreciate heard that 1,000,000 cases and I don’t are desirous to appreciate that lecture all over again?” Ard said.

This scenario, blended with past shortages of title-imprint variations of GLP-1s, equivalent to Ozempic, Mounjaro, and Trulicity, has created a “splendid storm” for telehealth companies to flourish, said Ard, who has obtained strengthen from pharmaceutical and telehealth companies.

While some telehealth companies prescribe splendid title-imprint weight loss tablets, many also provide more affordable, compounded variations. They act as intermediaries between prospects and mail-reveal compounding pharmacies, which get GLP-1s by mixing active ingredients, equivalent to semaglutide, with additives. The ingredients for compounded tablets are frequently sourced from in a single other nation suppliers, and the formulations are no longer reviewed by the FDA for security.

The environment is “very necessary uncontrolled and poorly, if at all, regulated,” Ard said. “There’s correct no long-established of care.”

Emily Hilliard, a spokesperson for the Department of Effectively being and Human Services and products, said that compounded tablets “must splendid be archaic in sufferers whose scientific needs cannot be met by an FDA-authorized drug.”

Hilliard said the agency urges “buyers to be vigilant and know the source of their tablets.”

Opinion the dangers

While weight loss tablets appreciate helped hundreds and hundreds of folks shed weight, they’re no longer with out trouble, the tips exhibits.

A KFF Effectively being Recordsdata files analysis of the FDA’s Opposed Occasion Monitoring Scheme chanced on that medication errors made by suppliers or sufferers with standard weight loss tablets exploded from correct over 2,000 experiences in 2020 to over 25,000 in 2025. These self-reported events eager semaglutide, tirzepatide, dulaglutide, and liraglutide, the generic names for main GLP-1s.

Among frequent issues cited in the adversarial match experiences had been administration of an additional or fallacious dose, issues with communication about a product, and prescribing errors.

Since 2019, the Nationwide Poison Recordsdata Scheme has fielded a practically 1,500% expand in calls linked to overdoses or aspect effects from injectable weight loss tablets. The files does no longer distinguish between overdoses tied to a telehealth prescription and americans stemming from an in-particular person scientific appointment, however it is a mirrored image of how prevalent these tablets appreciate change into.

But files on capability medication errors and adversarial reactions to GLP-1 medications is incomplete, on story of many issues are never reported to federal officials.

To illustrate, in a March 5 warning letter, the FDA accused drugmaker Novo Nordisk, the maker of Wegovy and Ozempic, of failing to epic some adversarial events to the federal authorities, including suicidal ideation and dying.

No person is aware of how frequently adversarial events happen, said Kristen Nixon, a Johns Hopkins University researcher who has studied posts about weight loss tablets on Reddit, a preferred on-line discussion board.

Her personnel analyzed a complete bunch of Reddit posts from 2020 through final August and known frequent mentions of drug reactions and user errors, equivalent to sufferers’ no longer vivid tips on how to accurately dose and inject the medication.

But one other finding also stood out to her.

“Wow, there are a range of folks talking about telehealth,” Nixon recalled pondering. Reddit commenters said they purchased GLP-1 prescriptions from rankings of telehealth platforms, Nixon chanced on. Commenters also mentioned several dozen compounding pharmacies — frequently in the identical posts about telehealth.

Pharmacies are on the total required to counsel sufferers on medications they receive. But Nixon’s learn chanced on that telehealth companies frequently mail the medications instantly, meaning sufferers ruin no longer must hotfoot to a pharmacy.

“Anecdotally, it seems to be love the telehealth companies are literally facilitating salvage entry to to compounded medications,” Nixon said.

Leslie Gammon, 54, an effect of enterprise supervisor from Wendell, North Carolina, said she turned to a telehealth company called Hobble Effectively being for a weight loss drug prescription. She change into given a GLP-1 after filling out an on-line get, she said.

Love McClain, when she obtained her mail-reveal compounded medication in slack October, she understanding the dosage that accompanied it gave the influence too high. She’d obtained a field of semaglutide earlier in the month with a substantial decrease dose. But the top off she obtained change into a stronger formulation, and the directions told Gammon to inject three cases the quantity she had been taking in earlier weeks.

Despite the incontrovertible reality that she injected a exiguous bit decrease than that instructed amount sooner than mattress on a Sunday evening, she awoke in the heart of the evening “throwing up every 20 to 25 minutes,” she said. And it didn’t stay until Tuesday. She change into in the end admitted to a successfully being heart in Raleigh and now owes the successfully being heart over $9,000, a scientific bill exhibits.

Hobble Effectively being didn’t answer to questions for this text.

The provide system for injectable variations of weight loss tablets is extra subtle than for a tablet. In its Nationwide Poison Recordsdata Scheme alert, The usa’s Poison Amenities eminent that some folks reported “by likelihood taking 10-cases the instructed dose on account of complicated measurement objects whereas the usage of a syringe.”

And folks that are enthusiastic to lose extra weight — sooner than a marriage or a hump, as an instance — can also fair resolve to self-administer an even bigger-than-instructed dose, said Arthur Caplan, a bioethics professor at Contemporary York University’s Grossman College of Treatment.

Some telehealth companies aren’t doing ample, he said, to be definite sufferers brand the dangers or the complex provide system associated with the injectable tablets.

“The consent is no longer enough,” Caplan said. “There’s no probing to search out out about while you understood anything.”

Cella, with the American Telemedicine Affiliation, said the neighborhood has no longer addressed the scenario of teaching sufferers about the dangers of injecting weight loss tablets. But she pointed to the affiliation’s “Principles of Notice,” which states that telehealth enterprise objects “must set up the patient first.”

Proceed with caution

Pharmaceutical companies must listing doubtlessly abominable aspect effects when they advertise the title-imprint variations of their FDA-authorized medications. Ability aspect effects of GLP-1s encompass nausea, vomiting, changes in vision, low blood sugar, and, in rare cases, thyroid cancer. Within the intervening time, telehealth companies appreciate no longer historically adopted the identical suggestions that drugmakers appreciate in disclosing medication dangers in commercials. But the FDA has started cracking down on deceptive drug commercials.

A nationwide shortage of weight loss medications in 2022 opened the door for compounding pharmacies to get these tablets. But since the FDA declared the dearth over final year, companies that present compounded tablets are increasingly extra dealing with apt and regulatory challenges linked to their marketing tactics.

Mounjaro manufacturer Eli Lilly and a amount of drugmakers are suing extra than one telehealth companies for selling compounded variations of their tablets. In a single apt complaint, Eli Lilly alleged Mochi Effectively being had engaged in “fraudulent” enterprise tactics. In a motion to brush off the lawsuit final year, lawyers for Mochi Effectively being called the complaint segment of a “nationwide campaign to bolster Lilly’s profits by dictating patient care throughout the elimination of compounded tablets as a treatment option for weight management.” The lawsuit is ongoing.

Eli Lilly spokesperson Michael Jamison said in a written observation that telehealth companies sued by the drug manufacturer threaten “patient security by falsely selling supposedly ‘personalized’ compounded tirzepatide” and lie to “buyers about the safety, clinical testing, and effectiveness of their compounded knockoffs.”

Within the intervening time, Novo Nordisk has filed 130 complaints in opposition to “entities engaged in unlawful marketing and sale of knockoff semaglutide tablets,” said Liz Skrbkova, a spokesperson for the drugmaker.

She said the corporate is dedicated to “protecting sufferers from unapproved knockoff tablets made with international, inauthentic active pharmaceutical ingredients that pose well-known security and efficacy dangers.”

The Trump administration sent a flurry of warning letters in September and February to on-line companies equivalent to Hims & Hers, SkinnyRx, Be half of Josie, and Genesis Effectively being World. The FDA said these and a amount of companies had made fraudulent or deceptive claims linked to compounded variations of weight loss tablets.

“Your claims indicate that your products are the identical as an FDA-authorized product when they devise no longer appear to be,” the agency’s Center for Drug Review and Analysis wrote to Hims & Hers on Sept. 9. The Department of Effectively being and Human Services and products later referred the corporate to the Department of Justice after it launched the launch of a $49 model of Novo Nordisk’s Wegovy tablet.

When requested about the FDA warning, Abby Reisinger-Moley, a spokesperson for Hims & Hers, pointed to a March assertion from the corporate announcing a shift away from compounded weight loss tablets. The company said in the clicking release that it had entered into an agreement with Novo Nordisk to sell title-imprint variations.

Alex Smith, CEO of Be half of Josie, an on-line platform that helps women in menopause shed weight by prescribing GLP-1s, said his company also made changes based utterly mostly on an FDA letter, to encompass taking out Be half of Josie’s title from medication vials. “Which I agree with,” Smith said, “on story of you don’t need sufferers pondering you’re the compounding pharmacy.”

SkinnyRx and Genesis Effectively being World didn’t answer to requests for observation.

But these warnings aren’t the first time the federal authorities has stepped in to be sure telemedicine is being archaic accurately, said Mei Wa Kwong, government director of the Center for Linked Effectively being Protection.

Prior cases eager consideration-deficit/hyperactivity disorder medications and a amount of controlled substances prescribed by telehealth suppliers, she said. While those tablets pose extra trouble to sufferers than GLP-1s, the companies had been also accused of improperly screening capability prospects.

The onus smooth falls on buyers to study companies sooner than signing up for his or her products and companies, Kwong said.

“Persistently formulation anything on the uncover with a splash of skepticism,” Kwong said.

‘Retains getting worse’

McClain, the Tennessee woman hospitalized this year after a GLP-1 overdose, said she lost 50 kilos about a years ago by taking a title-imprint GLP-1 prescribed by her doctor.

At the time, the medication change into covered by her successfully being insurance. This year, when she change into succesful of rob a GLP-1 all over again following a pregnancy, the drug change into no longer covered for weight loss.

To set up cash by obtaining a more affordable, compounded GLP-1, McClain signed up for Mochi Effectively being after doing her hang learn. “That change into correct essentially the most life like option,” she said.

But inside hours of her first dose, she said, she chanced on herself on the cell phone with poison have a watch on.

After her overdose, McClain said, she spoke to a clinical director at Mochi Effectively being, as soon as by cell phone however largely through e-mail, about her lingering symptoms sooner than communication paused.

David Pilip, a spokesperson for Mochi Effectively being, said in a assertion that the corporate wouldn’t focus on particular particular person sufferers on account of privacy tasks. But he said adversarial events are “straight flagged” and “investigated with crude precision.”

“Mochi Effectively being takes patient security extremely severely,” Pilip wrote in an e-mail. “We promptly initiated a review and were in instruct and ongoing communication with the patient to reach a resolution. We remain dedicated to doing so.”

McClain anticipates her healthcare payments linked to the successfully being heart end will complete no longer decrease than $900. She said that to salvage the $159 refund for her three-month membership and compensation for the successfully being heart prices, she has been requested to signal a doc announcing she received’t rob apt motion in opposition to the corporate. Her ride, she said, “correct keeps getting worse.”

CLARIFICATION: (Would per chance also 29, 2026, 7:forty eight p.m. ET): This article has been updated to clarify when Ro requires steady-time consultation with suppliers.

KFF Effectively being Recordsdata is a nationwide newsroom that produces in-depth journalism about successfully being issues.